홈 사이트맵   영문   중문

홍보센터공지사항
DFU2상 SAWC/WHS학회 초록 접수 완료
관리자
2018/12/20 548

다음과 같이 초록 접수 완료되었습니다.

Abstract Submission Site: Symposium on Advanced Wound Care-WHS Spring 2019

You can access your Abstract at any time

 

Abstract Type:

Poster if not accepted as an Oral Presentation

 

Abstract Status:

Complete

 

Abstract Title:

Prospective Single-blind Multi-Center Randomized Controlled Trial Comparing Allogenic Adipose Derived Stem Cell Hydrogel Versus Standard Wound Care To Evaluate Safety/Efficacy in Management of Non Healing Diabetic Foot Ulcers

 

Author(s)

 

1.David Armstrong, MD, DPM, PhD (Role: Author)

2.Seung-Kyu Han, MD, PhD (Role: Author)

3.Hyun-Suk Suh, MD, PhD (Role: Author)

4.Ki-Won Young, MD, PhD (Role: Author)

5.Charles M. ZELEN, DPM (Role:Author )
Abstract

 

Submission Title

 

Prospective, Single-blind, Multi-Center Randomized Controlled Trial Comparing Allogenic Adipose Derived Stem Cell - Hydrogel Versus Standard Wound Care To Evaluate Safety/ Efficacy in Management of Non Healing Diabetic Foot Ulcers

 

Track

 

Clinical Research

 

Has this abstract been previously presented?

•No

 Abstract

Mesenchymal stem cells (MSCs) hold great promise for treating diabetic wounds. Recent advancements in technology have led to the introduction of adipose derived allogeneic stem cells into a hydrogel sheet creating a unique medium for application on the non-healing diabetic foot wound.  The purpose of this phase II clinical trial was to report the efficacy and safety of allogeneic stem cells(ASC) for treating diabetic foot ulcers.  Fifty-nine patients with non healing diabetic foot ulcers, Wagner one and two, were randomized to receive either weekly application of ASC hydrogel sheets along with standard wound care(n = 30) or control group, treated with polyurethane film, also with standard wound care(n = 29).  These wounds were evaluated weekly for up to 12 weeks. The primary endpoint was complete wound closure at 12 weeks.

Primary: Allogenic stem cell sated onto a hydrogel sheet

Poster abstract sponsor

Anterogen Seoul Korea